Mark Kirby
Mark Kirby publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology, on topics such as Diabetes Treatment and Management, Peptidase Inhibition and Analysis and Neuropeptides and Animal Physiology.
- World rank
- #2,388,801 of 7,710,434 ranked researchers
- Rank in United States
- #708,968 of 1,627,098
- Works
- 43
- Citations
- 2.5k
- Citations per work
- 57.5
What does Mark Kirby research?
Mark Kirby's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (15%), Neuroscience (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1534.9%
- Medicine1534.9%
- Everything else1330.1%
- Life Sciences1227.5%
- Physical Sciences37.5%
- Chemistry37.5%
- 1Endocrinology, Diabetes and Metabolism18% of their works
- 2Molecular Biology15% of their works
- 3Oncology13% of their works
- 4Cellular and Molecular Neuroscience12% of their works
- 5Organic Chemistry8% of their works
- 6Surgery3% of their works
Research topics
Which keywords describe Mark Kirby's research?
The keywords of their largest research topics: Cardiovascular Outcomes, Type 2 Diabetes, Fibroblast Activation Protein, Tumor Microenvironment, Neuropeptides, Receptors, Hypertension and Aldosterone.
- Gut Microbiota
- Arachidonic Acid
- Primary Aldosteronism
- Nucleotide Metabolism
- Aldosterone
- Receptors
- Tumor Microenvironment
- Type 2 Diabetes
- Cardiovascular Outcomes
- Fibroblast Activation Protein
- Neuropeptides
- Hypertension
- Enzyme Regulation
- Pancreatic Islets
- ß-Cell Dysfunction
- Epoxyeicosatrienoic Acids
- Microbial Communities
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cardiovascular Outcomes181 topic
- Type 2 Diabetes181 topic
- Fibroblast Activation Protein161 topic
- Tumor Microenvironment161 topic
- Neuropeptides121 topic
- Receptors121 topic
- Hypertension52 topics
- Aldosterone31 topic
- Enzyme Regulation31 topic
- Nucleotide Metabolism31 topic
- Pancreatic Islets31 topic
- Primary Aldosteronism31 topic
- ß-Cell Dysfunction31 topic
- Arachidonic Acid21 topic
- Epoxyeicosatrienoic Acids21 topic
- Gut Microbiota21 topic
- Microbial Communities21 topic
Where does Mark Kirby work?
Mark Kirby's main affiliation in the publication record is Bristol-Myers Squibb (United States), United States.
How many publications and citations does Mark Kirby have?
OpenAlex counts 43 works and 2,472 citations for Mark Kirby, an h-index of 20, ranking #2,388,801 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Mark Kirby
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Kirby. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.